MyChesCo on MSN14h
AstraZeneca’s AZD0780 Shows Promising Results in Cholesterol-Lowering Clinical TrialNew data from the PURSUIT Phase IIb trial reveal AstraZeneca‘s investigational oral PCSK9 inhibitor, AZD0780, delivers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback